58P1D12 antibodies are particularly useful in cancer diagnostic and prognostic assays, and imaging methodologies. Similarly, such antibodies are useful in the treatment, diagnosis, and/or prognosis of ovarian and other cancers, to the extent 58P1D12 is also expressed or overexpressed in these other cancers.